Internal Medicine, Pulmonary Disease · Port St Lucie, FL
NPI
1912951740
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1700 SE Hillmoor Dr, Suite 200
Port St Lucie, FL, 34952
Phone (772) 335-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
3,314 services
Medicare patients, 2024
703
Average age 74
Drug cost, 2024
$2.0M
5,280 prescriptions
Company payments, 2025
$87K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bharat Upadhyay was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,050 times for 12 patients. In total Bharat Upadhyay billed 3,314 services in 69 codes, and Medicare paid $181K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-20.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,050 | 12 | $0.10 | $102 |
| 99214 Office E&M - Established | Office | 785 | 410 | $97.00 | $76K |
| 94727 Pulmonary Function Testing | Office | 172 | 171 | $35.76 | $6,151 |
| 94060 Pulmonary Function Testing | Office | 172 | 171 | $31.19 | $5,364 |
| 94729 Pulmonary Function Testing | Office | 172 | 171 | $44.99 | $7,738 |
| 71250 CT/CTA - Chest | Office | 153 | 136 | $64.80 | $9,914 |
| 99204 Office E&M - New | Office | 136 | 136 | $132.52 | $18K |
| 99215 Office E&M - Established | Office | 107 | 107 | $132.62 | $14K |
| 99213 Office E&M - Established | Office | 94 | 83 | $71.63 | $6,733 |
| 36415 Venipuncture Blood Collection | Office | 74 | 56 | $8.65 | $640 |
| 71046 X-ray - Chest | Office | 45 | 42 | $17.25 | $776 |
| 95800 Sleep Study | Office | 41 | 40 | $108.66 | $4,455 |
| 95810 Sleep Study | Office | 24 | 24 | $464.51 | $11K |
| 94618 Pulmonary Function Testing | Office | 21 | 21 | $28.50 | $599 |
| 95811 Sleep Study | Office | 17 | 17 | $528.75 | $8,989 |
By year: 2022 $175K for 3,343 services; 2023 $189K for 3,677 services; 2024 $181K for 3,314 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 74 | 56 | $8.65 | $640 |
Medicare prescription drug claims, 2024
In 2024, the drug Bharat Upadhyay prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,089 prescriptions and refills. In total Bharat Upadhyay wrote 5,280 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,089 | 1,293 | 340 | $31K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 549 | 828 | 158 | $513K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 427 | 650 | 114 | $403K |
| Azithromycin Generic | 265 | 407 | 125 | $4,429 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 234 | 385 | 73 | $179K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 226 | 343 | 59 | $155K |
| Prednisone Generic | 218 | 330 | 137 | $872 |
| Breo Ellipta Fluticasone/Vilanterol | 132 | 203 | 36 | $79K |
| Fluticasone Propionate Generic | 123 | 241 | 52 | $2,924 |
| Arnuity Ellipta Fluticasone Furoate | 105 | 161 | 27 | $31K |
| Pantoprazole Sodium Generic | 100 | 236 | 42 | $956 |
| Ventolin Hfa Albuterol Sulfate | 97 | 110 | 33 | $6,014 |
| Bevespi Aerosphere Glycopyrrolate/Formoterol Fum | 82 | 116 | 21 | $48K |
| Famotidine Generic | 79 | 225 | 33 | $1,177 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 73 | 133 | 35 | $14K |
Brand drugs: 2,753 claims; generic drugs: 2,527 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bharat Upadhyay $87K ($87K in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $87K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 69 | $87K |
| Verona Pharma, Inc. VRNA | 10 | $174 |
| Insmed, Inc. INSM | 4 | $127 |
| GlaxoSmithKline, LLC. GSK | 5 | $95.16 |
| Inspire Medical Systems, Inc. INSP | 2 | $73.5 |
| Vifor Pharma, Inc. | 2 | $48.32 |
| Fisher & Paykel Healthcare Inc FPH.NZ | 1 | $36.43 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $29.65 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $29.03 |
| Mallinckrodt Hospital Products Inc. | 1 | $23.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.